Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.
暂无分享,去创建一个
Olaf Sporns | Stanley Durrleman | Claudio Babiloni | Andrea Duggento | Nicola Toschi | Emiliano Santarnecchi | Jean Lorenceau | Olivier Colliot | Bruno Dubois | Stéphane Lehéricy | Karl Herholz | Keith L Black | Craig Ritchie | Simone Lista | Filippo Baldacci | Enrica Cavedo | Harald Hampel | Simone Rossi | Christian Neri | Francesco Garaci | Nathalie George | Andrea Vergallo | Francesco Cacciola | Erfan Younesi | Remy Genthon | Marie-Odile Habert | Arun L W Bokde | René S Bun | Patrizia A Chiesa | Cristina-Maria Coman | Maria-Teresa Ferretti | Yosef Koronyo | Maya Koronyo-Hamaoui | Foudil Lamari | Todd Langevin | Robert Nisticò | Francis Nyasse-Messene | Steven R Verdooner | Nicolas Villain | S. Rossi | O. Sporns | J. Lorenceau | N. Toschi | S. Lehéricy | B. Dubois | S. Durrleman | C. Babiloni | K. Herholz | A. Bokde | H. Hampel | F. Garaci | A. Duggento | O. Colliot | S. Lista | F. Lamari | E. Cavedo | E. Santarnecchi | K. Black | M. Ferretti | M. Habert | E. Younesi | C. Ritchie | R. Genthon | C. Néri | P. Chiesa | A. Vergallo | F. Baldacci | F. Cacciola | Y. Koronyo | M. Koronyo-Hamaoui | T. Langevin | R. Nisticò | S. Verdooner | Nicolas Villain | R. Bun | C. Coman | N. George | F. Nyasse-Messene
[1] W. M. van der Flier,et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. , 2016, Brain : a journal of neurology.
[2] Guido Gerig,et al. Spatiotemporal Atlas Estimation for Developmental Delay Detection in Longitudinal Datasets , 2009, MICCAI.
[3] Paul M. Thompson,et al. Staging Alzheimer's disease progression with multimodality neuroimaging , 2011, Progress in Neurobiology.
[4] Febo Cincotti,et al. Functional frontoparietal connectivity during short-term memory as revealed by high-resolution EEG coherence analysis. , 2004, Behavioral neuroscience.
[5] D. Parker,et al. Analysis of partial volume effects in diffusion‐tensor MRI , 2001, Magnetic resonance in medicine.
[6] Uma Maheswari Krishnan,et al. Mechanistic insights of curcumin interactions with the core-recognition motif of β-amyloid peptide. , 2013, Journal of agricultural and food chemistry.
[7] Nicola Toschi,et al. Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study. , 2017, Journal of Alzheimer's disease : JAD.
[8] S. Rossi,et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS) , 2017, Clinical Neurophysiology.
[9] Bradley T. Hyman,et al. The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.
[10] Keith L. Black,et al. Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.
[11] Chun-Hung Yeh,et al. Resolving crossing fibres using constrained spherical deconvolution: Validation using diffusion-weighted imaging phantom data , 2008, NeuroImage.
[12] Vince D. Calhoun,et al. Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.
[13] Serkan Kirbas,et al. Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[14] Kazuhiko Yanai,et al. Cholinergic Deficit and Response to Donepezil Therapy in Parkinson’s Disease with Dementia , 2012, European Neurology.
[15] Harald Hampel,et al. Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting. , 2015, Journal of Alzheimer's disease : JAD.
[16] P Pietrini,et al. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. , 1996, The American journal of psychiatry.
[17] S. Rossi,et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) , 2014, Clinical Neurophysiology.
[18] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[19] R. Näätänen,et al. The mismatch negativity (MMN) in basic research of central auditory processing: A review , 2007, Clinical Neurophysiology.
[20] M. van Buchem,et al. EEG Markers of Future Cognitive Performance in the Elderly , 2008, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[21] Rodrigo M. Braga,et al. Parallel Interdigitated Distributed Networks within the Individual Estimated by Intrinsic Functional Connectivity , 2017, Neuron.
[22] M. Fioravanti,et al. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study. , 1983, Clinical neuropharmacology.
[23] T. Wong,et al. Microvascular Structure and Network in the Retina of Patients With Ischemic Stroke , 2013, Stroke.
[24] David A. Leopold,et al. Dynamic functional connectivity: Promise, issues, and interpretations , 2013, NeuroImage.
[25] Hilkka Soininen,et al. Diffusion tensor imaging and Tract-Based Spatial Statistics in Alzheimer's disease and mild cognitive impairment , 2011, Neurobiology of Aging.
[26] Gustavo Deco,et al. Bottom up modeling of the connectome: Linking structure and function in the resting brain and their changes in aging , 2013, NeuroImage.
[27] S. Brassen,et al. Prediction of treatment response to rivastigmine in Alzheimer’s dementia , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[28] Pedro Rosa-Neto,et al. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals , 2014, Translational Neurodegeneration.
[29] S H Friend. The Need for Precompetitive Integrative Bionetwork Disease Model Building , 2010, Clinical pharmacology and therapeutics.
[30] M. T. Pascarelli,et al. ABNORMALITIES OF CORTICAL NEURAL SYNCHRONIZATION MECHANISMS IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S AND PARKINSON’S DISEASES: AN EEG STUDY , 2017, Alzheimer's & Dementia.
[31] Emiliano Santarnecchi,et al. Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease. , 2016, Current Alzheimer research.
[32] D. Yanagisawa,et al. In vivo detection of amyloid β deposition using 19F magnetic resonance imaging with a 19F-containing curcumin derivative in a mouse model of Alzheimer's disease , 2011, Neuroscience.
[33] D. Long. Networks of the Brain , 2011 .
[34] Didier Dormont,et al. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer’s disease? , 2012, Neuroradiology.
[35] D. O. Walter,et al. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. , 1987, Archives of general psychiatry.
[36] Elena Garcia-Martin,et al. Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia , 2015, Acta ophthalmologica.
[37] F. Pierelli,et al. Morphological and functional retinal impairment in Alzheimer's disease patients , 2001, Clinical Neurophysiology.
[38] Michael Breakspear,et al. Cortical Responses to a Graded Working Memory Challenge Predict Functional Decline in Mild Cognitive Impairment , 2011, Biological Psychiatry.
[39] H Kergoat,et al. An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. , 2001, Acta ophthalmologica Scandinavica.
[40] Olivier Rouaud,et al. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease. , 2016, The Journal of clinical psychiatry.
[41] M. Weiner,et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease* , 2009, Brain : a journal of neurology.
[42] Leslie G. Ungerleider,et al. Network analysis of cortical visual pathways mapped with PET , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] M. T. Pascarelli,et al. Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study , 2017, Neurobiology of Aging.
[44] Rainer Goebel,et al. Functional Imaging of Visuospatial Processing in Alzheimer's Disease , 2002, NeuroImage.
[45] Ryan Cross. This $25,000 physical has found some ‘serious’ health problems. Others say it has serious problems , 2017 .
[46] Claudio Del Percio,et al. Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study , 2006, Clinical Neurophysiology.
[47] C. DeCarli,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.
[48] J Driver,et al. Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory. , 2009, Brain : a journal of neurology.
[49] Ed X. Wu,et al. Advanced MR diffusion characterization of neural tissue using directional diffusion kurtosis analysis , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[50] Richard I. Morimoto,et al. Adapting Proteostasis for Disease Intervention , 2008, Science.
[51] A M Dale,et al. Prefrontal‐hippocampal‐fusiform activity during encoding predicts intraindividual differences in free recall ability: An event‐related functional‐anatomic MRI study , 2007, Hippocampus.
[52] Lilah M. Besser,et al. Neuropathologic differences by race from the National Alzheimer's Coordinating Center , 2016, Alzheimer's & Dementia.
[53] Adrian G. Palacios,et al. Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers , 2014, Alzheimer's & Dementia.
[54] E. Boyden,et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia , 2016, Nature.
[55] Hui Wang,et al. BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease , 2016, Neural regeneration research.
[56] J. Cummings,et al. Alzheimer's drug-development pipeline: 2016 , 2016, Alzheimer's & dementia.
[57] S. Borson,et al. Sleep Disturbances in Patients with Alzheimer’s Disease , 2001, CNS drugs.
[58] Tamiko R. MaGee,et al. Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints , 2013, Neurobiology of Aging.
[59] H. Depypere,et al. Alzheimer's disease, apolipoprotein E and hormone replacement therapy. , 2016, Maturitas.
[60] A. Nordberg,et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease , 2000, Neurobiology of Aging.
[61] Danielle S. Bassett,et al. Cognitive Network Neuroscience , 2015, Journal of Cognitive Neuroscience.
[62] Wolfgang Link,et al. Long live FOXO: unraveling the role of FOXO proteins in aging and longevity , 2015, Aging cell.
[63] M. Borchert,et al. Assessment of visual impairment in patients with Alzheimer's disease. , 1987, American journal of ophthalmology.
[64] Marie Chupin,et al. Spatial and Anatomical Regularization of SVM: A General Framework for Neuroimaging Data , 2013, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[65] M N Rossor,et al. Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.
[66] D Dressler,et al. A potential noninvasive neurobiological test for Alzheimer's disease. , 1994, Science.
[67] H. Heinsen,et al. Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease , 2012, Biological Psychiatry.
[68] H. Brodaty,et al. Functional Alterations in Brain Activation and Deactivation in Mild Cognitive Impairment in Response to a Graded Working Memory Challenge , 2011, Dementia and Geriatric Cognitive Disorders.
[69] Stefan Klöppel,et al. Multicenter stability of diffusion tensor imaging measures: A European clinical and physical phantom study , 2011, Psychiatry Research: Neuroimaging.
[70] Yanhui He,et al. Ginsenoside Rg1 Decreases Neurofibrillary Tangles Accumulation in Retina by Regulating Activities of Neprilysin and PKA in Retinal Cells of AD Mice Model , 2013, Journal of Molecular Neuroscience.
[71] R. Dolan,et al. Effects of Cholinergic Enhancement on Visual Stimulation, Spatial Attention, and Spatial Working Memory , 2004, Neuron.
[72] G. Tedrus,et al. Comparison of quantitative EEG between patients with Alzheimer’s disease and those with Parkinson’s disease dementia , 2013, Clinical Neurophysiology.
[73] Paul M. Thompson,et al. Genetics of the connectome , 2013, NeuroImage.
[74] Dietrich Lehmann,et al. Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease , 2008, Psychopharmacology.
[75] Li Guo,et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[76] Claudio Babiloni,et al. Global functional coupling of resting EEG rhythms is related to white-matter lesions along the cholinergic tracts in subjects with amnesic mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.
[77] Jan Sijbers,et al. Probabilistic fiber tracking using the residual bootstrap with constrained spherical deconvolution , 2011, Human brain mapping.
[78] Richard Armstrong,et al. Oculo‐visual changes and clinical considerations affecting older patients with dementia , 2015, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[79] Simone Lista,et al. Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease. , 2011, Biomarkers in medicine.
[80] Marco Bozzali,et al. Diffusion tensor MRI to investigate dementias: a brief review. , 2007, Magnetic resonance imaging.
[81] Martin Hofmann-Apitius,et al. Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration. , 2016, Journal of Alzheimer's disease : JAD.
[82] Amos D. Korczyn,et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2011, Clinical Neurology and Neurosurgery.
[83] Minoru Nakayama,et al. Feature analyses of pupil light reflex to chromatic stimuli in Alzheimer's patients , 2016, 2016 2nd International Conference on Frontiers of Signal Processing (ICFSP).
[84] W. Lukiw,et al. Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice. , 2015, Journal of inorganic biochemistry.
[85] Nick C Fox,et al. Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.
[86] P. Snyder,et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.
[87] K. Zilles,et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia , 2014, Molecular Psychiatry.
[88] John B. O. Mitchell,et al. Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies , 2016, Front. Neurosci..
[89] S. Hughes,et al. Thalamic Mechanisms of EEG Alpha Rhythms and Their Pathological Implications , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[90] Craig W. Ritchie,et al. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project , 2017, Alzheimer's & Dementia.
[91] D Liberati,et al. EEG coherence in Alzheimer's disease. , 1998, Electroencephalography and clinical neurophysiology.
[92] J. Rothwell,et al. Is there a future for therapeutic use of transcranial magnetic stimulation? , 2007, Nature Reviews Neuroscience.
[93] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[94] Paolo Maria Rossini,et al. Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data. , 2014, Journal of Alzheimer's disease : JAD.
[95] Henrik Zetterberg,et al. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. , 2016, JAMA neurology.
[96] J Anthony Movshon,et al. Putting big data to good use in neuroscience , 2014, Nature Neuroscience.
[97] Michal Schwartz,et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[98] Jan Sijbers,et al. Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data , 2014, NeuroImage.
[99] Stefan Skare,et al. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging , 2003, NeuroImage.
[100] Guido Gerig,et al. Geodesic Shape Regression in the Framework of Currents , 2013, IPMI.
[101] Kelly O'Keefe,et al. Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease , 2010, Alzheimer disease and associated disorders.
[102] Katsuhiro Kobayashi,et al. Memory enhancement and deep-brain stimulation of the entorhinal area. , 2012, The New England journal of medicine.
[103] Mads Nielsen,et al. Medical Image Computing and Computer-Assisted Intervention - MICCAI 2006, 9th International Conference, Copenhagen, Denmark, October 1-6, 2006, Proceedings, Part II , 2006, MICCAI.
[104] Shigehiro Morikawa,et al. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease. , 2010, Biomaterials.
[105] P Pietrini,et al. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[106] Nassir Navab,et al. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2013 , 2013, Lecture Notes in Computer Science.
[107] Thomas Dierks,et al. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease , 2000, Clinical Neurophysiology.
[108] P. Bosco,et al. Brain atrophy in Alzheimer’s Disease and aging , 2016, Ageing Research Reviews.
[109] Henrik Zetterberg,et al. CSF in Alzheimer's disease. , 2014, Advances in clinical chemistry.
[110] Juhani Partanen,et al. Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease , 1991, Neuroscience Letters.
[111] Owen Carmichael,et al. Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative , 2010, Alzheimer's & Dementia.
[112] Yi-Hsin Weng,et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. , 2011, Radiology.
[113] N. Toschi,et al. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[114] N. Toschi,et al. On the use of trace-weighted images in body diffusional kurtosis imaging. , 2016, Magnetic resonance imaging.
[115] G. Maru,et al. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. , 2010, Journal of agricultural and food chemistry.
[116] Michael W. Cole,et al. Activity flow over resting-state networks shapes cognitive task activations , 2016, Nature Neuroscience.
[117] Leroy Hood,et al. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.
[118] R. Reeves,et al. The Effects of Donepezil on Quantitative EEG in Patients with Alzheimer's Disease , 2002, Clinical EEG.
[119] M. Moschos,et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. , 2012, Current Alzheimer research.
[120] Stefan Teipel,et al. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease , 2014, Alzheimer's & Dementia.
[121] Evan M. Gordon,et al. Precision Functional Mapping of Individual Human Brains , 2017, Neuron.
[122] Martin Hofmann-Apitius,et al. ADO: A disease ontology representing the domain knowledge specific to Alzheimer's disease , 2014, Alzheimer's & Dementia.
[123] Kuncheng Li,et al. Visual attention deficits in Alzheimer's disease: an fMRI study , 2005, Neuroscience Letters.
[124] Club Jules Gonin,et al. Graefe's archive for clinical and experimental ophthalmology , 1982 .
[125] Yaniv Assaf,et al. Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain , 2005, NeuroImage.
[126] J. Trojanowski,et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.
[127] R. O’Connell,et al. Donepezil Impairs Memory in Healthy Older Subjects: Behavioural, EEG and Simultaneous EEG/fMRI Biomarkers , 2011, Alzheimer's & Dementia.
[128] R. L Gould,et al. FMRI BOLD response to increasing task difficulty during successful paired associates learning , 2003, NeuroImage.
[129] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[130] Woo Jin Park,et al. Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice , 2014, Neurobiology of Aging.
[131] A. Leuchter,et al. Effect of white matter disease on functional connections in the aging brain. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[132] G. Adler,et al. EEG coherence in Alzheimer’s dementia , 2003, Journal of Neural Transmission.
[133] Meindert Danhof,et al. Systems pharmacology - Towards the modeling of network interactions. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[134] Pedro Rosa-Neto,et al. Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[135] S. Petersen,et al. Brain Networks and Cognitive Architectures , 2015, Neuron.
[136] Andrea Gabrielli,et al. Non-Gaussian diffusion imaging: a brief practical review. , 2011, Magnetic resonance imaging.
[137] R. Buchert,et al. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment. , 2016, Journal of Alzheimer's disease : JAD.
[138] Michael I. Miller,et al. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease , 2012, Alzheimer's & Dementia.
[139] Harald Hampel,et al. Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease , 2010, Expert review of molecular diagnostics.
[140] Henrik Zetterberg,et al. Fluid biomarkers in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[141] R Cameron Craddock,et al. Disease state prediction from resting state functional connectivity , 2009, Magnetic resonance in medicine.
[142] B. Dubois,et al. PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease. , 2016, The journal of prevention of Alzheimer's disease.
[143] Claudio Del Percio,et al. Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment , 2014, Neurobiology of Aging.
[144] Lea T Grinberg,et al. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. , 2016, Cerebral cortex.
[145] T. Gasser,et al. EEG coherence in Alzheimer disease. , 1994, Electroencephalography and clinical neurophysiology.
[146] Olivier Colliot,et al. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. , 2016, Brain : a journal of neurology.
[147] Daniel L. Polders,et al. Multimodal tract-based analysis in ALS patients at 7T: A specific white matter profile? , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[148] S. Brassen,et al. Short-term Effects of Acetylcholinesterase Inhibitor Treatment on EEG and Memory Performance in Alzheimer Patients: an Open, Controlled Trial , 2003, Pharmacopsychiatry.
[149] Gordon H Baltuch,et al. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. , 2016, Journal of neurosurgery.
[150] Mohammad Asif Emon,et al. Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases , 2016, Journal of Alzheimer's disease : JAD.
[151] S. Lehéricy,et al. Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: A feasibility study , 2014, NeuroImage: Clinical.
[152] Karen M Rodrigue,et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. , 2015, JAMA.
[153] R. Blanks,et al. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL , 1996, Neurobiology of Aging.
[154] Cindee M. Madison,et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.
[155] Neta Zach,et al. Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation , 2016, Alzheimer's & Dementia.
[156] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[157] Olivier Colliot,et al. Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? , 2013, Alzheimer's & Dementia.
[158] Olivier Rouaud,et al. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease , 2017, Scientific Reports.
[159] Andreea Oliviana Diaconescu,et al. Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. , 2012, Archives of neurology.
[160] Xiaowei Yang,et al. Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine , 2014, PLoS Comput. Biol..
[161] J. Trojanowski,et al. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease , 2010, Experimental Gerontology.
[162] Adriaan A Lammertsma,et al. Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography. , 2016, Biochimica et biophysica acta.
[163] A. Kapasi,et al. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons. , 2016, Biochimica et biophysica acta.
[164] P. Scheltens,et al. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.
[165] Christian Böhm,et al. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.
[166] M. Weiner,et al. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia , 2011, Trends in Neurosciences.
[167] Gary H Lyman,et al. Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine. , 2016, The New England journal of medicine.
[168] Paul M. Thompson,et al. Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer’s Disease , 2017, Trends in Neurosciences.
[169] Alan Connelly,et al. SIFT: Spherical-deconvolution informed filtering of tractograms , 2013, NeuroImage.
[170] C. Jack,et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.
[171] S. Rossi,et al. P14.21 Frequency-dependent tuning of human motor system induced by transcranial oscillatory potentials , 2011, Clinical Neurophysiology.
[172] Paul M. Matthews,et al. Brain Microstructure Reveals Early Abnormalities more than Two Years prior to Clinical Progression from Mild Cognitive Impairment to Alzheimer's Disease , 2013, The Journal of Neuroscience.
[173] Jim Stack,et al. Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study. , 2014, Journal of Alzheimer's disease : JAD.
[174] Olivier Colliot,et al. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease , 2012, Neurobiology of Aging.
[175] A. Daly,et al. Pharmacogenetics and human genetic polymorphisms. , 2010, The Biochemical journal.
[176] Clive N Svendsen,et al. Ocular changes in TgF344-AD rat model of Alzheimer's disease. , 2014, Investigative ophthalmology & visual science.
[177] Edward T. Bullmore,et al. Fundamentals of Brain Network Analysis , 2016 .
[178] P. Sachdev,et al. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review , 2008, Current opinion in neurology.
[179] Emiliano Santarnecchi,et al. Non-invasive brain stimulation of the aging brain: State of the art and future perspectives , 2016, Ageing Research Reviews.
[180] C. Miller,et al. Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.
[181] James E. Morgan,et al. Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease , 2012, Neurobiology of Aging.
[182] David Craig,et al. Retinal microvascular network attenuation in Alzheimer's disease , 2015, Alzheimer's & dementia.
[183] Stephen M. Smith,et al. DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease , 2011, NeuroImage.
[184] Raymond J Dolan,et al. Maintenance versus manipulation in verbal working memory revisited: an fMRI study , 2003, NeuroImage.
[185] S. Rossi,et al. Frequency-Dependent Tuning of the Human Motor System Induced by Transcranial Oscillatory Potentials , 2011, The Journal of Neuroscience.
[186] G. Gilmore,et al. Motion perception and Alzheimer's disease. , 1994, Journal of gerontology.
[187] Chengjie Xiong,et al. Sleep quality and preclinical Alzheimer disease. , 2013, JAMA neurology.
[188] Jens H Jensen,et al. Progress in diffusion‐weighted imaging: concepts, techniques and applications to the central nervous system , 2010, NMR in biomedicine.
[189] Akihiko Takashima,et al. Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain. , 2012, The Journal of veterinary medical science.
[190] Klaus P. Ebmeier,et al. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease , 2011, Neurobiology of Aging.
[191] S. Muthukumaraswamy. The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG) , 2014, Journal of psychopharmacology.
[192] G B Frisoni,et al. The dynamic marker hypothesis of Alzheimer's disease and its implications for clinical imaging. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[193] Nicola Toschi,et al. Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology. , 2012, Sleep medicine.
[194] Bharat B. Biswal,et al. Inter-individual differences in resting-state functional connectivity predict task-induced BOLD activity , 2010, NeuroImage.
[195] Maximilian Reiser,et al. Multivariate network analysis of fiber tract integrity in Alzheimer’s disease , 2007, NeuroImage.
[196] Xudong Huang,et al. Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease , 2003, The Lancet.
[197] Nicola Toschi,et al. Early axonal damage in normal appearing white matter in multiple sclerosis: Novel insights from multi-shell diffusion MRI , 2017, 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[198] Jeannie-Marie S. Leoutsakos,et al. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.
[199] T. Wong,et al. Microvascular network alterations in the retina of patients with Alzheimer's disease , 2014, Alzheimer's & Dementia.
[200] Renato Anghinah,et al. Estudo da coerência do eletrencefalograma para a banda de frequência alfa em indivíduos adultos normais e com provável demência do tipo Alzheimer , 2000 .
[201] Emad N Eskandar,et al. Neuromodulation for restoring memory. , 2016, Neurosurgical focus.
[202] Michael W. Weiner,et al. The future of blood-based biomarkers for Alzheimer's disease , 2014, Alzheimer's & Dementia.
[203] P. Avanzini,et al. Melanopsin retinal ganglion cell loss in Alzheimer disease , 2015, Annals of neurology.
[204] P. Murali Doraiswamy,et al. Marked gender differences in progression of mild cognitive impairment over 8 years , 2015, Alzheimer's & dementia.
[205] R. Sperling,et al. Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[206] Olivier Colliot,et al. Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? , 2013, Alzheimer's & Dementia.
[207] Marie Chupin,et al. Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .
[208] Matthew J. Brookes,et al. Measuring functional connectivity using MEG: Methodology and comparison with fcMRI , 2011, NeuroImage.
[209] Timothy H. Muller,et al. Individual differences and specificity of prefrontal gamma frequency-tACS on fluid intelligence capabilities , 2016, Cortex.
[210] Philippe Robert,et al. Traitement symptomatique des troubles mnésiques de la maladie d’Alzheimer par stimulation électrique chronique du fornix dans l’hypothalamus , 2012 .
[211] J. Rabey,et al. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: clinical experience , 2016, Journal of Neural Transmission.
[212] Shannon L. Risacher,et al. Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials , 2016, Neurotherapeutics.
[213] Takashi Morihara,et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.
[214] E Macaluso,et al. Anisotropic anomalous diffusion assessed in the human brain by scalar invariant indices , 2010, Magnetic resonance in medicine.
[215] P. Thompson,et al. Local amygdala structural differences with 3T MRI in patients with Alzheimer disease , 2011, Neurology.
[216] M. Greicius,et al. Resting-state functional connectivity reflects structural connectivity in the default mode network. , 2009, Cerebral cortex.
[217] José Luis Molinuevo,et al. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. , 2016, The lancet. Psychiatry.
[218] P. Scheltens,et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.
[219] Harald Hampel,et al. Decreased activation along the dorsal visual pathway after a 3-month treatment with Galantamine in mild Alzheimer's disease , 2009 .
[220] N. Battistini,et al. Quantitative EEG mapping, regional cerebral blood flow, and neuropsychological function in Alzheimer's disease. , 1995, Dementia.
[221] Akram Bakkour,et al. The cortical signature of prodromal AD , 2009, Neurology.
[222] Eun Kyoung Ryu,et al. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.
[223] Lawrence R. Frank,et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.
[224] A Pääkkönen,et al. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. , 1991, Electroencephalography and clinical neurophysiology.
[225] Ryuji Kaji,et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis , 2017, Science Translational Medicine.
[226] Seth Blackshaw,et al. Vertebrate retina and hypothalamus development , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.
[227] Leon Lagnado,et al. The retina , 1999, Current Biology.
[228] A. Delacourte,et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.
[229] Knut Engedal,et al. Quantitative EEG Applying the Statistical Recognition Pattern Method: A Useful Tool in Dementia Diagnostic Workup , 2015, Dementia and Geriatric Cognitive Disorders.
[230] Andre Altmann,et al. Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.
[231] P Pietrini,et al. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. , 1998, The American journal of psychiatry.
[232] P. Riekkinen,et al. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy , 1993, Acta neurologica Scandinavica. Supplementum.
[233] Timothy Denison,et al. Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies , 2016, Front. Integr. Neurosci..
[234] Heinrich Garn,et al. Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features , 2017, Journal of Neural Transmission.
[235] Stefan Klöppel,et al. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. , 2014, Journal of Alzheimer's disease : JAD.
[236] E. Pekkonen. Mismatch Negativity in Aging and in Alzheimer’s and Parkinson’s Diseases , 2000, Audiology and Neurotology.
[237] E P Sloan,et al. Neurophysiology and SPECT cerebral blood flow patterns in dementia. , 1994, Electroencephalography and clinical neurophysiology.
[238] JoAnn E Manson,et al. Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes. , 2016, JAMA.
[239] C. Babiloni,et al. Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms. , 2016, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[240] D. Geschwind,et al. Correspondence between Resting-State Activity and Brain Gene Expression , 2015, Neuron.
[241] Giovanni Staurenghi,et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. , 2013, Investigative ophthalmology & visual science.
[242] Kazuyuki Uchida,et al. The binding of curcumin to various types of canine amyloid proteins. , 2012, The Journal of veterinary medical science.
[243] Keith L Black,et al. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. , 2015, Brain : a journal of neurology.
[244] A. Barabash,et al. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study. , 2016, Journal of Alzheimer's disease : JAD.
[245] Nicola Toschi,et al. Transcranial magnetic stimulation in heterogeneous brain tissue: clinical impact on focality, reproducibility and true sham stimulation. , 2009, Journal of psychiatric research.
[246] C. Jack,et al. β‐amyloid burden is not associated with rates of brain atrophy , 2008, Annals of neurology.
[247] M Corbetta,et al. A Dynamic Core Network and Global Efficiency in the Resting Human Brain. , 2016, Cerebral cortex.
[248] David Poeppel,et al. Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers , 2008, Biological Psychology.
[249] Francesco Pierelli,et al. Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis , 2015, PloS one.
[250] C. Jack,et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients , 2003, Neurology.
[251] A. Fagan,et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research , 2015, Alzheimer's & Dementia.
[252] Shannon L. Risacher,et al. Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data , 2017, Briefings Bioinform..
[253] R. Martins,et al. Multiplex biomarkers in blood , 2013, Alzheimer's Research & Therapy.
[254] Emiliano Ricciardi,et al. Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention , 2013, Neuropharmacology.
[255] Wang Zhan,et al. Group independent component analysis reveals consistent resting-state networks across multiple sessions , 2008, Brain Research.
[256] C. Babiloni,et al. Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms , 2006, Neuroscience.
[257] Matthew L Senjem,et al. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. , 2016, Brain : a journal of neurology.
[258] H. Möller,et al. Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: An fMRI study , 2008, Psychiatry Research: Neuroimaging.
[259] Keith A. Johnson,et al. Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.
[260] Inyoul Y. Lee,et al. Systems approach to neurodegenerative disease biomarker discovery. , 2014, Annual review of pharmacology and toxicology.
[261] Henri Wathieu,et al. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing , 2016, BMC Bioinformatics.
[262] Emiliano Ricciardi,et al. Cholinergic enhancement differentially modulates neural response to encoding during face identity and face location working memory tasks , 2013, Experimental biology and medicine.
[263] Olivier Colliot,et al. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. , 2014, Biochemical pharmacology.
[264] E. Mori,et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.
[265] Paul Maruff,et al. Nonvascular retinal imaging markers of preclinical Alzheimer's disease , 2016, Alzheimer's & dementia.
[266] Ying Liu,et al. Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease. , 2015, Archives of gerontology and geriatrics.
[267] Andrea Duggento,et al. MODELING OF HUMAN BAROREFLEX: CONSIDERATIONS ON THE SEIDEL–HERZEL MODEL , 2012 .
[268] L. Hood,et al. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.
[269] Daniel C Alexander,et al. Multiple‐Fiber Reconstruction Algorithms for Diffusion MRI , 2005, Annals of the New York Academy of Sciences.
[270] T Dierks,et al. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study , 2000, Clinical Neurophysiology.
[271] H. Hampel,et al. Alzheimer disease: From inherited to sporadic AD—crossing the biomarker bridge , 2012, Nature Reviews Neurology.
[272] Marco Rispoli,et al. Retinal Examination for the Diagnosis of Alzheimer's Disease , 2014 .
[273] C. Stam,et al. Phase lag index: Assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources , 2007, Human brain mapping.
[274] Samik Ghosh,et al. Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.
[275] B. Hyman,et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.
[276] Adriana Di Martino,et al. Age‐related non‐Gaussian diffusion patterns in the prefrontal brain , 2008, Journal of magnetic resonance imaging : JMRI.
[277] Jyrki Ahveninen,et al. Source estimation of spontaneous MEG oscillations in mild cognitive impairment , 2006, Neuroscience Letters.
[278] Stanley Durrleman,et al. Bayesian Mixed Effect Atlas Estimation with a Diffeomorphic Deformation Model , 2015, SIAM J. Imaging Sci..
[279] Ravi Iyengar,et al. Network analyses in systems pharmacology , 2009, Bioinform..
[280] Elena Vecino,et al. Glia–neuron interactions in the mammalian retina , 2016, Progress in Retinal and Eye Research.
[281] Eric Granholm,et al. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. , 2003, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[282] H. Rehm. Evolving health care through personal genomics , 2017, Nature Reviews Genetics.
[283] Sterling C. Johnson,et al. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function , 2015, NeuroImage.
[284] Radouil Tzekov,et al. Vision function abnormalities in Alzheimer disease. , 2014, Survey of ophthalmology.
[285] Boudewijn P. F. Lelieveldt,et al. Detection of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Longitudinal Brain MRI , 2017, Frontiers Neuroinformatics.
[286] Jochen Herms,et al. Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice , 2012, PloS one.
[287] Stefan Teipel,et al. STRUCTURAL CONNECTIVITY CHANGES UNDERLYING ALTERED WORKING MEMORY NETWORKS IN MILD COGNITIVE IMPAIRMENT: A THREE-WAY IMAGE FUSION ANALYSIS , 2014, Alzheimer's & Dementia.
[288] Frederik Barkhof,et al. Neurophysiological correlates of increased verbal working memory in high-dissociative participants: a functional MRI study , 2005, Psychological Medicine.
[289] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[290] B. Dubois,et al. A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling , 2017, Climacteric : the journal of the International Menopause Society.
[291] Zhikuan Yang,et al. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. , 2009, The American journal of pathology.
[292] H. Benali,et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. , 2008, Radiology.
[293] Matteo Pardini,et al. Long-term Cognitive and Behavioral Therapies, Combined with Augmentative Communication, are Related to Uncinate Fasciculus Integrity in Autism , 2011, Journal of Autism and Developmental Disorders.
[294] Nick C Fox,et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis , 2012, The Lancet Neurology.
[295] Russell A Poldrack,et al. Precision Neuroscience: Dense Sampling of Individual Brains , 2017, Neuron.
[296] Dirk C. Keene,et al. Suppressed Retinal Degeneration in Aged Wild Type and APPswe/PS1ΔE9 Mice by Bone Marrow Transplantation , 2013, PloS one.
[297] Nataša Pržulj,et al. Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.
[298] R. Martins,et al. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease , 2015, British Journal of Nutrition.
[299] G. Gambina,et al. Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease , 2014, International journal of geriatric psychiatry.
[300] Maija Pihlajamäki,et al. Increased fMRI responses during encoding in mild cognitive impairment , 2007, Neurobiology of Aging.
[301] Stefan J. Teipel,et al. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects , 2014, Alzheimer's & Dementia.
[302] Emiliano Santarnecchi,et al. Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[303] Victor L. Villemagne,et al. Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes , 2017, Alzheimer's & dementia.
[304] O. Sporns. Contributions and challenges for network models in cognitive neuroscience , 2014, Nature Neuroscience.
[305] P. J. Morin,et al. Amyloid Precursor Protein Is Synthesized by Retinal Ganglion Cells, Rapidly Transported to the Optic Nerve Plasma Membrane and Nerve Terminals, and Metabolized , 1993, Journal of neurochemistry.
[306] Francesco Garaci,et al. EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART , 2012 .
[307] Ian A. Cook,et al. Reduced EEG coherence in dementia: State or trait marker? , 1994, Biological Psychiatry.
[308] Fatmire Berisha,et al. Retinal abnormalities in early Alzheimer's disease. , 2007, Investigative ophthalmology & visual science.
[309] H. Hampel,et al. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases , 2017, Expert review of proteomics.
[310] I. Koerte,et al. Diffusion Tensor Imaging , 2014 .
[311] A. Korczyn,et al. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients , 2001, Journal of Neural Transmission.
[312] M. Soni,et al. Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[313] Xi Chen,et al. Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1ΔE9 mice and its immunomodulatory mechanisms. , 2015, Experimental eye research.
[314] Simone Lista,et al. Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease. , 2016, Methods in molecular biology.
[315] Marina Boccardi,et al. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework , 2017, Neurobiology of Aging.
[316] Olivier Salvado,et al. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease , 2014, NeuroImage: Clinical.
[317] Eric Guedj,et al. Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project , 2013, The Journal of Nuclear Medicine.
[318] E. Khedr,et al. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia , 2011, Journal of Neurology.
[319] G. Biessels,et al. Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging , 2014, Neurobiology of Aging.
[320] I. Fried,et al. Memory enhancement and deep-brain stimulation of the entorhinal area. , 2012, The New England journal of medicine.
[321] Joaquin Araya,et al. Alzheimer’s Disease-Related Protein Expression in the Retina of Octodon degus , 2015, PloS one.
[322] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[323] D O Walter,et al. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. , 1992, Brain : a journal of neurology.
[324] Jonathan D. Power,et al. Intrinsic and Task-Evoked Network Architectures of the Human Brain , 2014, Neuron.
[325] Terri L. Gilbert,et al. Neuropathological and transcriptomic characteristics of the aged brain , 2017, eLife.
[326] M. Tosetti,et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. , 2014, Radiology.
[327] Matthew S. Lebo,et al. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. , 2017, Annals of internal medicine.
[328] L. Pasquale,et al. Retinal blood flow in mild cognitive impairment and Alzheimer's disease , 2015, Alzheimer's & dementia.
[329] David T. Jones,et al. Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.
[330] Roberto Hornero,et al. MEG spectral profile in Alzheimer's disease and mild cognitive impairment , 2006, Clinical Neurophysiology.
[331] N. Mercuri,et al. Effect of Memantine on Resting State Default Mode Network Activity in Alzheimer’s Disease , 2011, Drugs & aging.
[332] P Julin,et al. Apolipoprotein E ε4 allele decreases functional connectivity in Alzheimer’s disease as measured by EEG coherence , 1997, Journal of neurology, neurosurgery, and psychiatry.
[333] Yaakov Stern,et al. An approach to studying the neural correlates of reserve , 2017, Brain Imaging and Behavior.
[334] Harald Hampel,et al. Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research , 2018, The Journal of Prevention of Alzheimer's Disease.
[335] Katharina Buerger,et al. Review Perspectives for Multimodal Neurochemical and Imaging Biomarkers in Alzheimer's Disease , 2022 .
[336] Cornelis J. Stam,et al. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease , 2005, NeuroImage.
[337] Paola Batistoni,et al. International Conference , 2001 .
[338] J. Baron,et al. In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.
[339] Patrik Vuilleumier,et al. Cholinergic enhancement modulates neural correlates of selective attention and emotional processing , 2003, NeuroImage.
[340] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[341] G. Kindlmann,et al. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images , 2006, Magnetic resonance in medicine.
[342] Stefan J. Teipel,et al. Decreased Activation Along the Dorsal Visual Pathway After a 3-Month Treatment With Galantamine in Mild Alzheimer Disease: A Functional Magnetic Resonance Imaging Study , 2009, Journal of clinical psychopharmacology.
[343] Ping Zhong,et al. Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons , 2015, Nature Communications.
[344] Cornelis J. Stam,et al. Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease , 2016, Alzheimer's & dementia.
[345] M. Rietschel,et al. Correlated gene expression supports synchronous activity in brain networks , 2015, Science.
[346] L. Parra,et al. Low-Intensity Electrical Stimulation Affects Network Dynamics by Modulating Population Rate and Spike Timing , 2010, The Journal of Neuroscience.
[347] Simon J Graham,et al. An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli , 2003, Neuropsychologia.
[348] Jennifer G. Robinson,et al. Sleep duration, cognitive decline, and dementia risk in older women , 2016, Alzheimer's & Dementia.
[349] J. Hardy,et al. Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease , 2017, Neurobiology of Aging.
[350] F De Vico Fallani,et al. Loss of brain inter-frequency hubs in Alzheimer's disease , 2016, Scientific Reports.
[351] N. Toschi,et al. Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain. , 2016, Medical physics.
[352] D. McCormick,et al. Endogenous Electric Fields May Guide Neocortical Network Activity , 2010, Neuron.
[353] Nobuaki Shirai,et al. Curcumin has binding activity to β-amyloid oligomer , 2011, Alzheimer's & Dementia.
[354] Claudio Babiloni,et al. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. , 2011, Journal of Alzheimer's disease : JAD.
[355] Alfredo A. Sadun,et al. Retinal ganglion cell degeneration in Alzheimer's disease , 1989, Brain Research.
[356] P. Vitali,et al. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease , 2004, Clinical Neurophysiology.
[357] Ivan Bodis-Wollner,et al. α‐synuclein in the inner retina in parkinson disease , 2014, Annals of neurology.
[358] Ronald G. García,et al. Complexity Variability Assessment of Nonlinear Time-Varying Cardiovascular Control , 2017, Scientific Reports.
[359] Reisa A. Sperling,et al. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer’s disease , 2015, Neuropsychologia.
[360] Yufeng Zang,et al. Linking inter-individual differences in neural activation and behavior to intrinsic brain dynamics , 2011, NeuroImage.
[361] Alan Wells,et al. Selection of models for the analysis of risk-factor trees: leveraging biological knowledge to mine large sets of risk factors with application to microbiome data , 2015, Bioinform..
[362] Loreto Gesualdo,et al. Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease , 2015, Neurobiology of Aging.
[363] P Pietrini,et al. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. , 1996, The American journal of psychiatry.
[364] Laura E. Matzen,et al. Frequency-Dependent Enhancement of Fluid Intelligence Induced by Transcranial Oscillatory Potentials , 2013, Current Biology.
[365] Essa Yacoub,et al. The WU-Minn Human Connectome Project: An overview , 2013, NeuroImage.
[366] P. Mecocci,et al. Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 , 2014, Journal of internal medicine.
[367] Richard F. Betzel,et al. Human Connectomics across the Life Span , 2017, Trends in Cognitive Sciences.
[368] Samik Ghosh,et al. AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease , 2012, BMC Systems Biology.
[369] Yong He,et al. Discrete Neuroanatomical Networks Are Associated with Specific Cognitive Abilities in Old Age , 2011, The Journal of Neuroscience.
[370] Cornelis J. Stam,et al. P1-388: Resting-state oscillatory brain dynamics in Alzheimer's disease , 2008, Alzheimer's & Dementia.
[371] K. Black,et al. Ocular indicators of Alzheimer’s: exploring disease in the retina , 2016, Acta Neuropathologica.
[372] Soon-Tae Lee,et al. White Matter Hyperintensities and Cognitive Dysfunction in Alzheimer Disease , 2009, Journal of geriatric psychiatry and neurology.
[373] R. Wennberg,et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease , 2010, Annals of neurology.
[374] D. Louis Collins,et al. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity , 2015, Alzheimer's & Dementia.
[375] Alberto Fernández,et al. MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications. , 2013, Journal of Alzheimer's disease : JAD.
[376] Nick C Fox,et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. , 2000, Archives of neurology.
[377] Stefanie Brassen,et al. Short-Term Rivastigmine Treatment Reduces EEG Slow-Wave Power in Alzheimer Patients , 2001, Neuropsychobiology.
[378] Giovanni B. Frisoni,et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment , 2017, Alzheimer's & Dementia.
[379] A. Fagan,et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease , 2015, Alzheimer's & Dementia.
[380] M. Vidal. A unifying view of 21st century systems biology , 2009, FEBS letters.
[381] Robert Turner,et al. Slice accelerated diffusion‐weighted imaging at ultra‐high field strength , 2014, Magnetic resonance in medicine.
[382] Jon Snaedal,et al. Retinal oximetry imaging in Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[383] C. Rowe,et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease , 2013, Translational Psychiatry.
[384] E. Mori,et al. The processing of global and local visual information in Alzheimer's disease. , 2000, Behavioural neurology.
[385] H Katsunuma,et al. Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease , 1998, Psychiatry and clinical neurosciences.
[386] Stanley Durrleman,et al. Learning spatiotemporal trajectories from manifold-valued longitudinal data , 2015, NIPS.
[387] Dezhong Yao,et al. Large-Scale Functional Networks Identified from Resting-State EEG Using Spatial ICA , 2016, PloS one.
[388] Hamid Soltanian-Zadeh,et al. Diffusion kurtosis imaging discriminates patients with white matter lesions from healthy subjects , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[389] Timothy O. Laumann,et al. Functional Network Organization of the Human Brain , 2011, Neuron.
[390] David A. Rottenberg. The cortical signature of prodromal AD? , 2009 .
[391] Concha Bielza,et al. Bayesian networks in neuroscience: a survey , 2014, Front. Comput. Neurosci..
[392] Harald Hampel,et al. Alzheimer disease: functional abnormalities in the dorsal visual pathway. , 2010, Radiology.
[393] Mary J. Morrell,et al. The Association Between Obstructive Sleep Apnea and Alzheimer’s Disease: A Meta-Analysis Perspective , 2016, Front. Aging Neurosci..
[394] Wanlin Zhu,et al. Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[395] Simone Lista,et al. Blood and plasma-based proteomic biomarker research in Alzheimer's disease , 2013, Progress in Neurobiology.
[396] Cleofé Peña-Gómez,et al. Brain connectivity during resting state and subsequent working memory task predicts behavioural performance , 2012, Cortex.
[397] R. Adolphs,et al. Building a Science of Individual Differences from fMRI , 2016, Trends in Cognitive Sciences.
[398] N. Schuff,et al. Headache and cerebral venous air embolism , 2007, Neurology.
[399] Derek K. Jones. Studying connections in the living human brain with diffusion MRI , 2008, Cortex.
[400] P. Selnes,et al. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. , 2013, Journal of Alzheimer's disease : JAD.
[401] Marco Weiergräber,et al. Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements , 2011, Progress in Neurobiology.
[402] N. Ponomareva,et al. EEG Alterations in Subjects at High Familial Risk for Alzheimer’s Disease , 2003, Neuropsychobiology.
[403] Wendy R. Sanhai,et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.
[404] Mark W. Woolrich,et al. Integrating cross-frequency and within band functional networks in resting-state MEG: A multi-layer network approach , 2016, NeuroImage.
[405] Wanlin Zhu,et al. White matter integrity in mild cognitive impairment: A tract-based spatial statistics study , 2010, NeuroImage.
[406] Patrizia Rizzu,et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia , 2013, Neurology.
[407] R. Bajo,et al. MEG spectral analysis in subtypes of mild cognitive impairment , 2014, AGE.
[408] Daniel Rueckert,et al. Medical Image Computing and Computer-Assisted Intervention − MICCAI 2017: 20th International Conference, Quebec City, QC, Canada, September 11-13, 2017, Proceedings, Part II , 2017, Lecture Notes in Computer Science.
[409] Walter Stark,et al. Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients , 2014, Brain pathology.
[410] John R Hetling,et al. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. , 2015, Experimental eye research.
[411] Kenji Sakuma,et al. Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer's disease , 2005, Journal of the Neurological Sciences.
[412] P. Basser,et al. Axcaliber: A method for measuring axon diameter distribution from diffusion MRI , 2008, Magnetic resonance in medicine.
[413] Emery N. Brown,et al. Author Correction: Gamma frequency entrainment attenuates amyloid load and modifies microglia , 2018, Nature.
[414] Evelien Vandewalle,et al. Retinal Oximetry Discovers Novel Biomarkers in Retinal and Brain Diseases. , 2017, Investigative ophthalmology & visual science.
[415] N. Toschi,et al. Technical note: DTI measurements of fractional anisotropy and mean diffusivity at 1.5 T: comparison of two radiofrequency head coils with different functional designs and sensitivities. , 2011, Medical physics.
[416] Nick C Fox,et al. Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease , 2005, Neurology.
[417] Nicola Toschi,et al. A reconstruction of the conductive phenomena elicited by transcranial magnetic stimulation in heterogeneous brain tissue. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[418] E. Niedermeyer. Alpha rhythms as physiological and abnormal phenomena. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[419] Vincenzo Crunelli,et al. Cellular Dynamics of Cholinergically Induced α (8–13 Hz) Rhythms in Sensory Thalamic Nuclei In Vitro , 2008, The Journal of Neuroscience.
[420] Guido Gerig,et al. Morphometry of anatomical shape complexes with dense deformations and sparse parameters , 2014, NeuroImage.
[421] A. Sadun,et al. Optic nerve damage in Alzheimer's disease. , 1990, Ophthalmology.
[422] Karen F Berman,et al. The neurobiology of Alzheimer disease defined by neuroimaging. , 2012, Current opinion in neurology.
[423] M. Corbetta,et al. Temporal dynamics of spontaneous MEG activity in brain networks , 2010, Proceedings of the National Academy of Sciences.
[424] Martijn P. van den Heuvel,et al. Rich Club Organization and Cognitive Performance in Healthy Older Participants , 2015, Journal of Cognitive Neuroscience.
[425] Cindee M. Madison,et al. Comparing predictors of conversion and decline in mild cognitive impairment , 2010, Neurology.
[426] Francesco Carlo Morabito,et al. A Longitudinal EEG Study of Alzheimer's Disease Progression Based on A Complex Network Approach , 2015, Int. J. Neural Syst..
[427] Stanley Durrleman,et al. A Bayesian Mixed-Effects Model to Learn Trajectories of Changes from Repeated Manifold-Valued Observations , 2017, J. Mach. Learn. Res..
[428] Michael I. Jordan,et al. Kernel independent component analysis , 2003 .
[429] C. Geula,et al. Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer’s disease , 1999, Acta Neuropathologica.
[430] N. Schuff,et al. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection , 2015, The Lancet Neurology.
[431] Richard A. P. Roche,et al. Identification of Resting State Networks Involved in Executive Function , 2016, Brain Connect..
[432] J. Rabey,et al. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study , 2013, Journal of Neural Transmission.
[433] Simone Lista,et al. Biological and methodical challenges of blood-based proteomics in the field of neurological research , 2013, Progress in Neurobiology.
[434] Pietro Gori,et al. A Bayesian framework for joint morphometry of surface and curve meshes in multi‐object complexes , 2017, Medical Image Anal..
[435] G. Glover,et al. Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control , 2007, The Journal of Neuroscience.
[436] Menggang Yu,et al. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy , 2017, JAMA oncology.
[437] Nicola Toschi,et al. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. , 2013, The Medical clinics of North America.
[438] Constantine G. Lyketsos,et al. 130 Bilateral Fornix Deep Brain Stimulation for Alzheimer Disease: Surgical Safety in the ADvance Trial , 2015 .
[439] Matthew J. Brookes,et al. A multi-layer network approach to MEG connectivity analysis , 2016, NeuroImage.
[440] Alexei Verkhratsky,et al. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease. , 2014, Experimental eye research.
[441] Verner Knott,et al. Acute Nicotine Administration in Alzheimer’s Disease: An Exploratory EEG Study , 2000, Neuropsychobiology.
[442] O. Sporns,et al. Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.
[443] Alonso Emilio,et al. β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment , 2012, EMBO molecular medicine.
[444] T. Montine,et al. White matter lesions defined by diffusion tensor imaging in older adults , 2011, Annals of neurology.
[445] Seray Aslan Bayhan,et al. Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral‐domain optical coherence tomography , 2015, Clinical & experimental ophthalmology.
[446] Paolo Maria Rossini,et al. Jitter of Corticospinal Neurons During Repetitive Transcranial Magnetic Stimulation. Method and Possible Clinical Implications , 2014, Brain Stimulation.
[447] Herbert A. Reitsamer,et al. Brain and Retinal Pericytes: Origin, Function and Role , 2016, Front. Cell. Neurosci..
[448] C. Curcio,et al. Retinal ganglion cells in Alzheimer's disease and aging , 1993, Annals of neurology.
[449] Jeremy D. Schmahmann,et al. Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers , 2008, NeuroImage.
[450] Reisa A. Sperling,et al. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits , 2015, Neurobiology of Aging.
[451] Xinqing Zhang,et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography , 2010, Neuroscience Letters.
[452] Piet Van Mieghem,et al. Disruption of Functional Brain Networks in Alzheimer's Disease: What Can We Learn from Graph Spectral Analysis of Resting-State Magnetoencephalography? , 2012, Brain Connect..
[453] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[454] Sebastien Ourselin,et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. , 2014, JAMA neurology.
[455] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[456] Julián Benito-León,et al. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[457] J. Cummings,et al. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.
[458] Leslie G. Ungerleider,et al. Effect of task difficulty on cerebral blood flow during perceptual matching of faces , 1996, Human brain mapping.
[459] Simone Lista,et al. Biomarkers in Sporadic and Familial Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[460] Emiliano Santarnecchi,et al. State-Dependent Effects of Transcranial Oscillatory Currents on the Motor System: What You Think Matters , 2013, The Journal of Neuroscience.
[461] Harald Hampel,et al. Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement , 2013, The journal of nutrition, health & aging.
[462] A. Maubon,et al. Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease , 2015, Alzheimer's & Dementia.
[463] Luca Citi,et al. Assessment of spontaneous cardiovascular oscillations in Parkinson's disease , 2016, Biomed. Signal Process. Control..
[464] F. D’Antonio,et al. Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. , 2014, Journal of Alzheimer's disease : JAD.
[465] S. Resnick,et al. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.
[466] Yogesan Kanagasingam,et al. Ocular biomarkers for early detection of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[467] S. Balkan,et al. Effect of donepezil on EEG spectral analysis in Alzheimer's disease. , 2003, Acta neurologica Belgica.
[468] Dag Aarsland,et al. Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease , 2015, Neurodegenerative Diseases.
[469] Alex Becker,et al. In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.
[470] Tim B. Dyrby,et al. Orientationally invariant indices of axon diameter and density from diffusion MRI , 2010, NeuroImage.
[471] Masud Husain,et al. Alzheimer's disease: time to focus on the brain, not just molecules. , 2017, Brain : a journal of neurology.
[472] Andrea Duggento,et al. Intra- and inter-beat modeling of cardiovascular dynamics and control: Assessing haemodynamic stability and responsiveness , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[473] M. Giovannini,et al. The fate of the brain cholinergic neurons in neurodegenerative diseases , 2017, Brain Research.
[474] Martin Hofmann-Apitius,et al. Challenges and opportunities for oncology biomarker discovery. , 2013, Drug discovery today.
[475] M. Storandt,et al. A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years. , 1985, Electroencephalography and clinical neurophysiology.
[476] Z. Yue,et al. Neuronal aggregates: formation, clearance, and spreading. , 2015, Developmental cell.
[477] P. Sachdev,et al. Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[478] K Broich,et al. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. , 2014, The journal of prevention of Alzheimer's disease.
[479] I. Deary,et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures , 2005, Journal of anatomy.
[480] Ariadna Besga,et al. Structural and Functional Patterns in Healthy Aging, Mild Cognitive Impairment, and Alzheimer Disease , 2010, Alzheimer disease and associated disorders.
[481] Claudio Babiloni,et al. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging. , 2014, Journal of Alzheimer's disease : JAD.
[482] M. Raichle,et al. Resting-state activity in development and maintenance of normal brain function , 2011, Proceedings of the National Academy of Sciences.
[483] Z. Khachaturian,et al. Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot , 2012, Alzheimer's & Dementia.
[484] E. Melhem,et al. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. , 2007, Radiology.
[485] Harald Hampel,et al. Biological markers of amyloid β-related mechanisms in Alzheimer's disease , 2010, Experimental Neurology.
[486] N. Toschi,et al. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease , 2017, Neurochemistry International.
[487] L Guo,et al. Alzheimer's disease and retinal neurodegeneration. , 2009, Current Alzheimer research.
[488] Karl J. Friston,et al. The mismatch negativity: A review of underlying mechanisms , 2009, Clinical Neurophysiology.
[489] Pietro Gori,et al. Joint Morphometry of Fiber Tracts and Gray Matter Structures Using Double Diffeomorphisms , 2015, IPMI.
[490] Muhammad Abuzar Fahiem,et al. An Ensemble-of-Classifiers Based Approach for Early Diagnosis of Alzheimer's Disease: Classification Using Structural Features of Brain Images , 2014, Comput. Math. Methods Medicine.
[491] Guido Gerig,et al. Analysis of Longitudinal Shape Variability via Subject Specific Growth Modeling , 2012, MICCAI.
[492] Chunbo Li,et al. Greater attenuation of retinal nerve fiber layer thickness in Alzheimer's disease patients. , 2014, Journal of Alzheimer's disease : JAD.
[493] Georg Winterer,et al. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1‐year follow‐up study , 2008, International journal of geriatric psychiatry.
[494] Matthew L Senjem,et al. Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks , 2009, Journal of the International Neuropsychological Society.
[495] Xuelian Wang,et al. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse , 2013, Neuroscience Letters.
[496] Nicola Toschi,et al. Imaging epigenetics in Alzheimer's disease. , 2013, Current pharmaceutical design.
[497] Stephen G Oliver,et al. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks. , 2016, Methods in molecular biology.
[498] Harald Hampel,et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. , 2015, Brain : a journal of neurology.
[499] Veselka Boeva,et al. A formal concept analysis approach to consensus clustering of multi-experiment expression data , 2014, BMC Bioinformatics.
[500] G. Tedrus,et al. Alzheimer's disease: relationship between cognitive aspects and power and coherence EEG measures. , 2011, Arquivos de neuro-psiquiatria.
[501] L. Shah,et al. Reliability and reproducibility of individual differences in functional connectivity acquired during task and resting state , 2016, Brain and behavior.
[502] K. Blennow,et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.
[503] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[504] A. Barabasi,et al. Interactome Networks and Human Disease , 2011, Cell.
[505] Gerda Thomsen,et al. Striatal Dopamine Transporter Binding Does Not Correlate with Clinical Severity in Dementia with Lewy Bodies , 2013, The Journal of Nuclear Medicine.
[506] Roland Opfer,et al. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[507] R. Barbieri,et al. Globally conditioned Granger causality in brain–brain and brain–heart interactions: a combined heart rate variability/ultra-high-field (7 T) functional magnetic resonance imaging study , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[508] Eleanor To,et al. Amyloid- β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease , 2008 .
[509] M S Buchsbaum,et al. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. , 1995, Neuropsychobiology.
[510] Stefan J. Teipel,et al. Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's disease , 2011, Progress in Neurobiology.
[511] Alain Trouvé,et al. Statistical models of sets of curves and surfaces based on currents , 2009, Medical Image Anal..
[512] Armin Scheurich,et al. Altered whole-brain white matter networks in preclinical Alzheimer's disease , 2015, NeuroImage: Clinical.
[513] Leroy Hood,et al. Systems Approaches to Biology and Disease Enable Translational Systems Medicine , 2012, Genom. Proteom. Bioinform..
[514] H. Möller,et al. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study , 2016, Psychiatry Research: Neuroimaging.
[515] James C. Vickers,et al. Amyloid β accumulation and inner retinal degenerative changes in Alzheimer’s disease transgenic mouse , 2016, Neuroscience Letters.
[516] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[517] C. Stam. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders , 2010, Journal of the Neurological Sciences.
[518] Stanley Durrleman,et al. Statistical Learning of Spatiotemporal Patterns from Longitudinal Manifold-Valued Networks , 2017, MICCAI.
[519] Martin Hofmann-Apitius,et al. Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis , 2015, Alzheimer's & Dementia.
[520] Sid O'Bryant,et al. Developing novel blood-based biomarkers for Alzheimer's disease , 2014, Alzheimer's & Dementia.
[521] Alberto Fernández,et al. IC-P-046 Magnetoencephalography (MEG) parietal delta dipole density in mild cognitive impairment: Preliminary results of a method to estimate the risk of developing Alzheimer’s disease , 2006, Alzheimer's & Dementia.
[522] Efstathios D. Gennatas,et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. , 2010, Brain : a journal of neurology.
[523] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[524] Chia-Hsiung Cheng,et al. Inadequate inhibition of redundant auditory inputs in Alzheimer's disease: An MEG study , 2012, Biological Psychology.
[525] C. J. Stam,et al. Alzheimer’s disease: The state of the art in resting-state magnetoencephalography , 2017, Clinical Neurophysiology.
[526] T. Gale,et al. Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis , 2012, Journal of clinical and experimental neuropsychology.
[527] Evan M. Gordon,et al. Functional System and Areal Organization of a Highly Sampled Individual Human Brain , 2015, Neuron.
[528] M. Rask-Andersen,et al. Trends in the exploitation of novel drug targets , 2011, Nature Reviews Drug Discovery.
[529] M. Hofmann-Apitius,et al. From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine , 2013, EPMA Journal.
[530] Giuliano Binetti,et al. Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future , 2011, Neurodegenerative Diseases.
[531] Nicola Toschi,et al. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. , 2015, Journal of Alzheimer's disease : JAD.
[532] Markus Zahn,et al. Transcranial direct current stimulation: A computer-based human model study , 2007, NeuroImage.
[533] Vinod Menon,et al. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[534] Wiesje M. van der Flier,et al. Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints , 2013, Alzheimer's & Dementia.
[535] R. Dolan,et al. Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. , 2008, Brain : a journal of neurology.
[536] M. Barris,et al. Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type , 1989, Annals of neurology.
[537] D. Bennett,et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study , 2006, Neurobiology of Aging.
[538] H. Adeli,et al. Intrahemispheric, interhemispheric, and distal EEG coherence in Alzheimer’s disease , 2011, Clinical Neurophysiology.
[539] Michael Weiner,et al. Breakdown of Brain Connectivity Between Normal Aging and Alzheimer's Disease: A Structural k-Core Network Analysis , 2013, Brain Connect..
[540] Claudio Babiloni,et al. Cross-sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in the WP5 PharmaCog/E-ADNI study , 2013, Alzheimer's & Dementia.
[541] H. Hampel,et al. Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease , 2017, Expert review of neurotherapeutics.
[542] S. Hughes,et al. Temporal Framing of Thalamic Relay-Mode Firing by Phasic Inhibition during the Alpha Rhythm , 2009, Neuron.
[543] Harald Hampel,et al. The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study , 2011, Human brain mapping.
[544] Nicola Toschi,et al. Quantifying uncertainty in Transcranial Magnetic Stimulation - A high resolution simulation study in ICBM space , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[545] Robert Kromer,et al. Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT , 2014, Front. Psychiatry.
[546] Charles Auffray,et al. Participatory medicine: a driving force for revolutionizing healthcare , 2013, Genome Medicine.
[547] Viswanath Devanarayan,et al. Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge , 2016, Alzheimer's & Dementia.
[548] Eva Meisenzahl,et al. Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.
[549] Michael Wagner,et al. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. , 2017, Journal of Alzheimer's disease : JAD.
[550] Christopher P Hess,et al. Update on diffusion tensor imaging in Alzheimer's disease. , 2009, Magnetic resonance imaging clinics of North America.
[551] James T. Becker,et al. Magnetoencephalography as a Putative Biomarker for Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[552] M. Weiner,et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.
[553] L R Trick,et al. Visual field loss in senile dementia of the Alzheimer's type , 1995, Neurology.
[554] Jesse Jackson,et al. Alterations in hippocampal network oscillations and theta–gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease , 2013, The European journal of neuroscience.
[555] P. Vitali,et al. Quantitative EEG Changes in Alzheimer Patients during Long-Term Donepezil Therapy , 2002, Neuropsychobiology.
[556] Erfan Younesi,et al. SVM Based Descriptor Selection and Classification of Neurodegenerative Disease Drugs for Pharmacological Modeling , 2013, Molecular informatics.
[557] C. Jack,et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria , 2016, Alzheimer's & Dementia.
[558] Alan C. Evans,et al. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. , 2006, Brain : a journal of neurology.
[559] M. Breakspear,et al. The connectomics of brain disorders , 2015, Nature Reviews Neuroscience.
[560] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[561] Stefan Klöppel,et al. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. , 2015, Journal of Alzheimer's disease : JAD.
[562] Olivier Colliot,et al. The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study. , 2010, Journal of Alzheimer's disease : JAD.
[563] Cornelis J Stam,et al. Resting-State Oscillatory Brain Dynamics in Alzheimer Disease , 2008, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[564] E. Londos,et al. Electroencephalogram Variability in Dementia with Lewy Bodies, Alzheimer’s Disease and Controls , 2008, Dementia and Geriatric Cognitive Disorders.
[565] Takashi Inoue,et al. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging , 2002, Neuroscience Letters.
[566] P. Bartenstein,et al. Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.
[567] O. Sporns,et al. Network neuroscience , 2017, Nature Neuroscience.
[568] D. Prattichizzo,et al. High-gamma oscillations in the motor cortex during visuo-motor coordination: A tACS interferential study , 2017, Brain Research Bulletin.
[569] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[570] W D Obrist,et al. Effects of task difficulty on regional cerebral blood flow: relationships with anxiety and performance. , 1988, Psychophysiology.
[571] Kazuyuki Takeda,et al. Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils. , 2011, Bioorganic & medicinal chemistry.
[572] J. Kaye,et al. Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility , 2017, Alzheimer's & Dementia.
[573] Guido Gerig,et al. Toward a Comprehensive Framework for the Spatiotemporal Statistical Analysis of Longitudinal Shape Data , 2013, International Journal of Computer Vision.
[574] Jonathan D. Cohen,et al. Dissociating working memory from task difficulty in human prefrontal cortex , 1997, Neuropsychologia.
[575] Gungor Sobaci,et al. Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. , 2011, Brain : a journal of neurology.
[576] P. Walla,et al. Depth of word processing in Alzheimer patients and normal controls: a magnetoencephalographic (MEG) study , 2005, Journal of Neural Transmission.
[577] R. Floris,et al. White matter reduced streamline coherence in young men with autism and mental retardation , 2009, European journal of neurology.
[578] Jean-Philippe Vert,et al. The Wnt Receptor Ryk Reduces Neuronal and Cell Survival Capacity by Repressing FOXO Activity During the Early Phases of Mutant Huntingtin Pathogenicity , 2014, PLoS biology.
[579] Gwenn S. Smith,et al. Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease , 2015, Brain Stimulation.
[580] L. Westlye,et al. Mini-Mental State Examination Is Sensitive to Brain Atrophy in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.
[581] H. Möller,et al. EEG coherence reflects regional corpus callosum area in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[582] Michael W. Weiner,et al. Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans , 2010, Neurobiology of Aging.
[583] Vikas Prasad,et al. Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients. , 2016, Journal of Alzheimer's disease : JAD.
[584] Joseph A. Helpern,et al. White matter characterization with diffusional kurtosis imaging , 2011, NeuroImage.
[585] Urs P Mosimann,et al. The retina in Parkinson's disease. , 2009, Brain : a journal of neurology.
[586] Jan Trøst. Companion diagnostics: the key to personalized medicine , 2015 .
[587] K. Blennow,et al. Fluid biomarkers in Alzheimer’s disease – current concepts , 2013, Molecular Neurodegeneration.
[588] P. Campo,et al. Medial temporal lobe neuromagnetic hypoactivation and risk for developing cognitive decline in elderly population: A 2-year follow-up study , 2006, Neurobiology of Aging.
[589] Simone Lista,et al. Dementia: The rising global tide of cognitive impairment , 2016, Nature Reviews Neurology.
[590] Thomas Dierks,et al. Dementia of the alzheimer type: Effects on the spontaneous EEG described by dipole sources , 1993, Psychiatry Research: Neuroimaging.
[591] A. Bokde,et al. Task difficulty in a simultaneous face matching task modulates activity in face fusiform area. , 2005, Brain research. Cognitive brain research.
[592] G. Barnes,et al. Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco‐magnetoencephalography , 2009, Human brain mapping.
[593] Taylor W Schmitz,et al. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology , 2016, Nature communications.
[594] M. Albert,et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[595] M. Onofrj,et al. The Effects of a Cholinesterase Inhibitor Are Prominent in Patients With Fluctuating Cognition: A Part 3 Study of the Main Mechanism of Cholinesterase Inhibitors in Dementia , 2003, Clinical neuropharmacology.
[596] Aileen I. Pogue,et al. Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease , 2011, Neuroreport.
[597] Colin L. Masters,et al. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[598] Johan H. C. Reiber,et al. MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease , 2008, NeuroImage.
[599] N. Logothetis,et al. Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.
[600] A. Flanders. Optic Nerve and Optic Radiation Neurodegeneration in Patients with Glaucoma: In Vivo Analysis with 3-T Diffusion-Tensor MR Imaging , 2010 .
[601] H. Möller,et al. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.
[602] Akinori Nakamura,et al. Source analysis of spontaneous magnetoencephalograpic activity in healthy aging and mild cognitive impairment: influence of apolipoprotein E polymorphism. , 2014, Journal of Alzheimer's disease : JAD.
[603] P F Sharp,et al. Multimodal Imaging in Alzheimer's Disease , 1990, British Journal of Psychiatry.
[604] K. Blennow,et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia , 2017, Alzheimer's & Dementia.
[605] G Mariani,et al. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[606] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[607] Swati S. More,et al. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline. , 2015, ACS chemical neuroscience.
[608] Sang Won Seo,et al. Distribution of amyloid burden in PiB(+) subcortical vascular cognitive impairment compared with Alzheimer's disease , 2013, Alzheimer's & Dementia.
[609] S. Rossi,et al. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines , 2017, Clinical Neurophysiology.
[610] Alberto Fernández,et al. Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. , 2003, AJNR. American journal of neuroradiology.
[611] Jaeseung Jeong. EEG dynamics in patients with Alzheimer's disease , 2004, Clinical Neurophysiology.
[612] H. Soininen,et al. Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. , 1989, Electroencephalography and clinical neurophysiology.
[613] Simone Lista,et al. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges , 2015, Alzheimer's & dementia.
[614] Abraham Z. Snyder,et al. Frequency specific interactions of MEG resting state activity within and across brain networks as revealed by the multivariate interaction measure , 2013, NeuroImage.
[615] Claire Paquet,et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2007, Neuroscience Letters.
[616] Yuehua Wu,et al. Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer’s disease , 2015, BMC Neurology.